Alignment Healthcare (ALHC)
(Delayed Data from NSDQ)
$11.45 USD
+0.14 (1.24%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.44 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.45 USD
+0.14 (1.24%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $11.44 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Zacks News
Alignment HealthCare Partners With Intermountain Health in Nevada
by Zacks Equity Research
ALHC partners with Intermountain Health to enhance access to high-quality care for Medicare members in Clark and Washoe counties, starting Jan 2025.
Alignment Healthcare (ALHC) Moves 12.7% Higher: Will This Strength Last?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Bausch + Lomb (BLCO) Surges 14.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Bausch + Lomb (BLCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Alignment Healthcare (ALHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 7.14% and 7.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Alignment Healthcare (ALHC) Surges 11.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Compared to Estimates, Alignment Healthcare (ALHC) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of -4.17% and 5.13%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Ascend Wellness Holdings, Inc. (AAWH) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Ascend Wellness Holdings, Inc. (AAWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Alignment Healthcare (ALHC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alignment Healthcare (ALHC) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stay Ahead of the Game With Alignment Healthcare (ALHC) Q4 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Alignment Healthcare (ALHC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Cheniere (LNG) Pull Off a Strong Show in Q4 Earnings?
by Zacks Equity Research
Robust export volumes and lower costs are likely to have boosted Cheniere Energy's (LNG) profit levels in the fourth quarter.
Factors to Note Ahead of Coterra Energy's (CTRA) Q4 Earnings
by Zacks Equity Research
Coterra Energy (CTRA) beat the Zacks Consensus Estimate for earnings in each of the last four quarters, resulting in an earnings surprise of 111.8%, on average.
Alignment Healthcare (ALHC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Alignment Healthcare (ALHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analyzing 3 Healthcare Stocks Poised for Q4 Earnings Beat
by Kaibalya Pravo Dey
Rising patient volumes, admissions, health awareness and technological advancements in the Q4 are likely to have benefited healthcare players like Universal Health (UHS), Alignment Healthcare (ALHC) and Agiliti (AGTI).
Alignment Healthcare (ALHC) Moves 13.2% Higher: Will This Strength Last?
by Zacks Equity Research
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Alignment Healthcare (ALHC) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Alignment Healthcare (ALHC) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alignment Healthcare (ALHC) Surges 17.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Alignment Healthcare (ALHC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Alignment Healthcare (ALHC) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Alignment Healthcare (ALHC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 28.57% and 5.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CareDx (CDNA) Soars 20.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
CareDx (CDNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alignment Healthcare (ALHC) delivered earnings and revenue surprises of 20% and 1.87%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?